Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/23/2025

Tapering and Stopping Cymbalta (Duloxetine) Guidelines

Introduction to Tapering

  • The Centers for Disease Control and Prevention recommends beginning with a reduction of approximately 10% of the original dose per week as a reasonable starting point, with slower tapers (10% per month or less) for patients on Cymbalta long-term 1, 2
  • Tapering plans should be individualized based on current dose, duration of treatment, and patient response, according to the Centers for Disease Control and Prevention 1

Tapering Protocols

  • For standard capsules, consider alternating day dosing in the final stages of tapering, as suggested by the American Academy of Sleep Medicine 3
  • The American Academy of Sleep Medicine also notes that withdrawal symptoms typically appear within days of dose reduction and may last 1-3 days per step 3

Managing Withdrawal Symptoms

  • Consider supportive medications to manage specific symptoms, such as short-term use of trazodone for anxiety or irritability, as recommended by the Mayo Clinic 4
  • The American Academy of Sleep Medicine suggests using sleep hygiene measures and possibly short-term sleep aids for sleep disturbances 3
  • The Mayo Clinic recommends appropriate symptomatic treatments for gastrointestinal symptoms 4

Special Considerations

  • Pause tapering and restart when the patient is ready if withdrawal symptoms become severe, as advised by the Centers for Disease Control and Prevention 1, 2
  • Successful tapering may require several weeks to months, especially after long-term use, according to the American Academy of Sleep Medicine 3
  • The American Academy of Sleep Medicine also suggests considering cognitive-behavioral therapies during tapering to increase rates of successful discontinuation 3
  • The Mayo Clinic recommends discussing with patients that withdrawal symptoms are not necessarily a sign that they need to continue the medication long-term 4

Common Pitfalls to Avoid

  • Avoid tapering too quickly, which increases withdrawal risk, as warned by the Centers for Disease Control and Prevention 1
  • Do not mistake withdrawal symptoms for recurrence of the original condition, as cautioned by the Mayo Clinic 4
  • The Mayo Clinic also notes that protracted withdrawal may occur months after discontinuation, with symptoms including dysphoria, irritability, and insomnia 4

When to Seek Additional Help

  • If symptoms of the original condition worsen significantly during tapering, seek additional help, as recommended by the Centers for Disease Control and Prevention 1

REFERENCES

3

clinical guideline for the evaluation and management of chronic insomnia in adults. [LINK]

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2008